Venture Capital

Xconomy: Relay Lays $200M Ipo Plan To Fund Tests Of Protein Motion Cancer Drugs

by posted 8months ago 17 views
Sophisticated computational tools have guided Relay Therapeutics in its efforts to develop new drugs based on analysis of the movement and shape of disease-causing proteins. Now the Cambridge, MA, biotech is looking to tap the public markets to bulk up company coffers and get its two lead drug candidates into mid-stage clinical trials as potential […]

In this article